Skip to main content

Market Overview

Jaguar Health Says It Has Regained Nasdaq Compliance


Jaguar Health Inc (NASDAQ: JAGX) said Monday evening it has regained compliance with all applicable Nasdaq Stock Market listing standards.

Jaguar Health says it received a letter from the Nasdaq on June 21, confirming that the bid price deficiency of Jaguar has been fixed, and that the company is in compliance with all applicable listing standards.

Jaguar Health is a pharmaceutical company focused on developing sustainably derived gastrointestinal products.

Jaguar Health shares traded higher by 1.7% at $4.64 at time of publication.

Related Links:

Jaguar Health Spikes 50% After Subsidiary Receives Preclinical Services From NIAID

Acer Therapeutics Shares Plunge On FDA Complete Response Letter


Related Articles (JAGX)

View Comments and Join the Discussion!

Posted-In: News Legal

Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at